Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tongluo Jiunao
- Development stage
- Unknown
- Lead developer
- Inner Mongolia Kangyuan Pharmaceutical
- Administration
- Intravenous
01
Overview
Tongluo Jiunao is a Traditional Chinese Medicine (TCM) injection developed by Inner Mongolia Kangyuan Pharmaceutical for the treatment of acute cerebral infarction (ischemic stroke). It is a standardized herbal preparation primarily composed of extracts from *Panax notoginseng* (Sanchi) and *Gardenia jasminoides* (Zhizi), with key active constituents including ginsenoside Rg1, ginsenoside Rb1, and geniposide. The drug is designed to address the TCM syndrome of 'wind-fire disturbing upward and blood stasis blocking collaterals.' Mechanistically, Tongluo Jiunao provides neuroprotection by reducing cerebral edema, inhibiting inflammatory cytokine release, and preventing neuronal apoptosis in the ischemic penumbra. It has undergone Phase II clinical evaluation in China to assess its safety and efficacy in patients during the acute phase of stroke.
- Brand names
- Tongluo Jiunao
- Other names
- Tongluo Jiunao Injection
02
Targets
Aβ (Amyloid-beta peptides and aggregates)NTRK3 (Tropomyosin receptor kinase C)
Beyond the preview
Go deeper on Tongluo Jiunao.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tongluo Jiunao.